Philip Ball | Market Access Manager
Napp Pharmaceuticals

Philip Ball, Market Access Manager, Napp Pharmaceuticals

Philip is the Market Access lead for Napp’s biosimilar portfolio and has first-hand experience in supporting uptake of both immunology and cancer biosimilars across the UK healthcare system. Prior to working in Market Access, Philip studied biology and molecular genetics at the University of Bristol and started his career at Roche in 2006. He has held a number of Medical Information, Medical Writing and Scientific Advisor roles in the pharmaceutical Industry.


Biosimilars Day 1 - Tuesday 31st October 2017 @ 11:35

Plenary Roundtable Discussion Session

8 senior level tables hosted by thought leaders on key challenges and opportunities in antibody drug development. Participants are invited to join the group discussions on a topic of importance to them.

WORKSHOP HOSTED BY NICE Understanding issues around market access

back to speakers